Skip to main content

Table 1 HIV-1 Subtypes and Antiretroviral Drug Mutations in Twenty-Seven Beninese-Naive Patients

From: Moderate rate of transmitted resistance mutations to antiretrovirals and genetic diversity in newly HIV-1 patients diagnosed in Benin

Samples ID Age (years) Viral load (Log10) Drug Resistance Mutations Associated HIV-1 subtypes
PI* NRTI* NNRTI* NRTI + NNRTI*
Ben148 31 5.52 K103N URF (CRF02_AG/A3)
Ben 784 34 4.31 K103N CRF02_AG
Ben 538 42 5.81 M184V G
Ben 169 33 6.2 G190A URF (CRF06_cpx/A)
Ben 18 36 5.04 I85V CRF02_AG
Ben 226 35 5.7 K103N A3
Ben 230 25 5.37 K103N CRF02_AG
Ben 232 20 6.57 M184V URF (CRF02_AG/A1)
Ben 255 30 5.39 K103N CRF02_AG
Ben 722 29 5.28 D67N K103N D67N, K103N CRF02_AG
Ben 607 40 3.45 M184V V106A, G190A M184V, V106A, G190A G
Ben 96 31 5.85 L90M CRF02_AG
Ben 98 43 4.97 K103N CRF06_cpx
Ben 687 28 5.28 M41L K103N M41L, K103N URF (CRF06_cpx/CRF02_AG)
Ben 420 25 631 M184V URF (CRF06_cpx/CRF02_AG/A3)
Ben 643 20 5.54 Y188L CRF02_AG
Ben 657 42 5.6 T215S CRF02_AG
Ben 206 41 5.27 K103N, P225H CRF02_AG
Ben 208 26 4.99 M184V CRF02_AG
Ben 211 51 4.31 K103N CRF02_AG
Ben 212 35 4.18 K65R, M184I K103N, Y188L K65R, M184I, K103N, Y188L CRF02_AG
Ben 213 35 5.58 M184V Y181C M184V, Y181C G
Ben 214 45 5.97 K103N CRF02_AG
Ben 216 37 6.68 M184V URF (CRF02_AG/U)
Ben 218 52 5.06 K103N A3
Ben 390 52 5.67 K103N CRF02_AG
Ben 101 45 5.39 D67G, K70R, M184V K219Q V106M, Y181C, G190A D67G, K70R, M184V, K219Q
V106M, Y181C, G190A
G
  1. NRTI nucleoside reverse transcriptase inhibitors, NNRTI nonnucleoside reverse transcriptase inhibitors, PI protease inhibitors, URF unique recombinant forms, Ben Benin
  2. *According to the WHO algorithm for Surveillance of Drug Resistance Mutations (SDRM), 2009